LUDG.US Ludwig Enterprises Inc
- Market cap
- USD 669K
- P/E
- 0.4x
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is LUDG.US undervalued?
Graham numberThe Graham number of Ludwig Enterprises Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ludwig Enterprises Inc fundamental analysis
No fundamental analysis for Ludwig Enterprises Inc yet.
Ludwig Enterprises Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ludwig Enterprises Inc
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-inva…
Full company profileLudwig Enterprises Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ludwig Enterprises Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0.00 | - | - | - | 126K | - | 0.00 | 0.00 | 217.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | - | - | - | -29.3K | - | 0.00 | 0.00 | 217.00 | - | - |
| Operating Income | -5.16K | -5.86K | -5.02K | -78.4K | -34.1K | -45.7K | -561K | -1.45M | -1.30M | -1.77M | -2.26M |
| EBITDA | -5.16K | -5.86K | -5.02K | -78.4K | -5.32K | -45.7K | 44.5K | -1.50M | -2.29M | -1.35M | -1.68M |
| Net Income | 133K | -10.3K | -10.6K | -85.1K | -54.2K | -137K | -965K | -2.46M | -3.02M | -2.24M | 875K |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | -0.01 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 5.81K | 6.63K | 6.41K | 625K | 623K | 125K | 516K | 112K | 198K | 248K | 1.26M |
| Total Liabilities | 14.1K | 45.5K | 55.9K | 713K | 745K | 183K | 1.34M | 1.57M | 2.58M | 4.64M | 5.29M |
| Shareholders' Equity | -8.28K | -38.9K | -49.5K | -88.0K | -122K | -57.7K | -826K | -1.46M | -2.38M | -4.39M | -4.03M |
| Cash & Short-term Investments | 4.81K | 5.63K | 5.41K | 11.2K | 8.85K | 125K | 516K | 108K | 6.74K | 0.00 | 18.3K |
| Total Debt | 14.1K | 24.8K | 24.8K | 690K | 697K | 136K | 1.34M | 1.37M | 1.95M | 2.50M | 2.66M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 133K | -1.06K | -220.00 | -85.1K | -28.8K | -45.7K | -445K | -648K | -660K | -645K | -611K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.17K | 0.00 |
| Free Cash Flow | 133K | -1.06K | -220.00 | -85.1K | -28.8K | -45.7K | -445K | -648K | -660K | -645K | -611K |
| Ratios | |||||||||||
| ROA | 2,285.9% | -154.7% | -164.7% | -13.6% | -8.7% | -110.0% | -187.0% | -2,184.2% | -1,527.1% | -903.5% | 69.2% |
| Net Profit Margin | - | - | - | - | -43.1% | - | - | - | -1,390,269.1% | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ludwig Enterprises Inc dividends
Ludwig Enterprises Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:350 on May 16, 2012.
Who owns Ludwig Enterprises Inc
- Insiders 41.10%
- Institutions 0.00%
- Public & others 58.90%
- Shares outstanding 167M
- Free float 93.9M
Ludwig Enterprises Inc company profile
- Company name
- Ludwig Enterprises Inc
- Ticker
- LUDG.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 5
- Fiscal year end
- December
- Address
- 8950 SW 74th Ct, Miami, FL, United States, 33156
- Phone
- 786 363 0166
- Website
- ludwigent.com
About Ludwig Enterprises Inc
Ludwig Enterprises, Inc. operates as a genomic technology focused on developing testing approaches for inflammation-related chronic diseases, including cancers in the United States. The company integrates mRNA inflammatory biomarkers, proprietary machine-learning algorithms, and at-home cheek swab collection kits for cancer identification. It offers mRNA-based screening to provide early insights of potential health risks. The company develops Revealia Breast test, a non-invasive cheek swab screening kit designed to identify and analyze molecular signatures in mRNA expression associated with inflammation-related biological processes associated with the presence of breast cancer. Ludwig Enterprises, Inc. was founded in 1988 and is based in Miami, Florida.
Ludwig Enterprises Inc management
3- Mr. Jose Antonio ReyesInterim CEO & President · born 1966
- Mr. Scott J. SilvermanCFO, Secretary, Treasurer & Director · born 1970
- Dr. Marvin S. Hausman M.D.Chief Science Officer · born 1941